Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Spine Biologics Market Overview
3.1 Global Spine Biologics Market Historical Value (2019-2025)
3.2 Global Spine Biologics Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Spine Biologics Market Landscape*
5.1 Global Spine Biologics Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Spine Biologics Market: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Surgery Type
6 Global Spine Biologics Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Spine Biologics Market Segmentation (2019-2035)
7.1 Global Spine Biologics Market (2019-2035) by Product Type
7.1.1 Market Overview
7.1.2 Bone Graft
7.1.2.1 Spine Autografts
7.1.2.2 Spine Allografts
7.1.3 Bone Graft Substitutes
7.1.3.1 Bone Morphogenetic Proteins (BMP)
7.1.3.2 Demineralized Bone Matrix (DMB)
7.1.3.3 Synthetic Bone Grafts
7.1.4 Platelet Rich Plasma (PRP)
7.1.5 Bone Marrow Aspirate (BMAC) Therapy
7.2 Global Spine Biologics Market (2019-2035) by Surgery Type
7.2.1 Market Overview
7.2.2 Anterior Cervical Discectomy and Fusion (ACDF)
7.2.3 Transforaminal Lumbar Interbody Fusion (TLIF)
7.2.4 Posterior Lumbar Interbody Fusion (PLIF)
7.2.5 Anterior Lumbar Interbody Fusion (ALIF)
7.2.6 Lateral Lumbar Interbody Fusion (LLIF)
7.3 Global Spine Biologics Market (2019-2035) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Specialty Clinics
7.3.4 Ambulatory Surgical Centers (ASCs)
7.3.5 Academic and Research Institutes
7.3.6 Others
7.4 Global Spine Biologics Market (2019-2035) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Spine Biologics Market (2019-2035)
8.1 North America Spine Biologics Market (2019-2035) by Product Type
8.1.1 Market Overview
8.1.2 Bone Graft
8.1.2.1 Spine Autografts
8.1.2.2 Spine Allografts
8.1.3 Bone Graft Substitutes
8.1.3.1 Bone Morphogenetic Proteins (BMP)
8.1.3.2 Demineralized Bone Matrix (DMB)
8.1.3.3 Synthetic Bone Grafts
8.1.4 Platelet Rich Plasma (PRP)
8.1.5 Bone Marrow Aspirate (BMAC) Therapy
8.2 North America Spine Biologics Market (2019-2035) by Surgery Type
8.2.1 Market Overview
8.2.2 Anterior Cervical Discectomy and Fusion (ACDF)
8.2.3 Transforaminal Lumbar Interbody Fusion (TLIF)
8.2.4 Posterior Lumbar Interbody Fusion (PLIF)
8.2.5 Anterior Lumbar Interbody Fusion (ALIF)
8.2.6 Lateral Lumbar Interbody Fusion (LLIF)
8.3 North America Spine Biologics Market (2019-2035) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Ambulatory Surgical Centers (ASCs)
8.3.5 Academic and Research Institutes
8.3.6 Others
8.4 North America Spine Biologics Market (2019-2035) by Country
8.4.1 United States of America
8.4.1.1 United States of America Spine Biologics Market (2019-2035) by Product Type
8.4.2 Canada
8.4.2.1 Canada Spine Biologics Market (2019-2035) by Product Type
9 Europe Spine Biologics Market (2019-2035)
9.1 Europe Spine Biologics Market (2019-2035) by Product Type
9.1.1 Market Overview
9.1.2 Bone Graft
9.1.2.1 Spine Autografts
9.1.2.2 Spine Allografts
9.1.3 Bone Graft Substitutes
9.1.3.1 Bone Morphogenetic Proteins (BMP)
9.1.3.2 Demineralized Bone Matrix (DMB)
9.1.3.3 Synthetic Bone Grafts
9.1.4 Platelet Rich Plasma (PRP)
9.1.5 Bone Marrow Aspirate (BMAC) Therapy
9.2 Europe Spine Biologics Market (2019-2035) by Surgery Type
9.2.1 Market Overview
9.2.2 Anterior Cervical Discectomy and Fusion (ACDF)
9.2.3 Transforaminal Lumbar Interbody Fusion (TLIF)
9.2.4 Posterior Lumbar Interbody Fusion (PLIF)
9.2.5 Anterior Lumbar Interbody Fusion (ALIF)
9.2.6 Lateral Lumbar Interbody Fusion (LLIF)
9.3 Europe Spine Biologics Market (2019-2035) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Ambulatory Surgical Centers (ASCs)
9.3.5 Academic and Research Institutes
9.3.6 Others
9.4 Europe Spine Biologics Market (2019-2035) by Country
9.4.1 United Kingdom
9.4.1.1 United Kingdom Spine Biologics Market (2019-2035) by Product Type
9.4.2 Germany
9.4.2.1 Germany Spine Biologics Market (2019-2035) by Product Type
9.4.3 France
9.4.3.1 France Spine Biologics Market (2019-2035) by Product Type
9.4.4 Italy
9.4.4.1 Italy Spine Biologics Market (2019-2035) by Product Type
9.4.5 Others
10 Asia Pacific Spine Biologics Market (2019-2035)
10.1 Asia Pacific Spine Biologics Market (2019-2035) by Product Type
10.1.1 Market Overview
10.1.2 Bone Graft
10.1.2.1 Spine Autografts
10.1.2.2 Spine Allografts
10.1.3 Bone Graft Substitutes
10.1.3.1 Bone Morphogenetic Proteins (BMP)
10.1.3.2 Demineralized Bone Matrix (DMB)
10.1.3.3 Synthetic Bone Grafts
10.1.4 Platelet Rich Plasma (PRP)
10.1.5 Bone Marrow Aspirate (BMAC) Therapy
10.2 Asia Pacific Spine Biologics Market (2019-2035) by Surgery Type
10.2.1 Market Overview
10.2.2 Anterior Cervical Discectomy and Fusion (ACDF)
10.2.3 Transforaminal Lumbar Interbody Fusion (TLIF)
10.2.4 Posterior Lumbar Interbody Fusion (PLIF)
10.2.5 Anterior Lumbar Interbody Fusion (ALIF)
10.2.6 Lateral Lumbar Interbody Fusion (LLIF)
10.3 Asia Pacific Spine Biologics Market (2019-2035) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Ambulatory Surgical Centers (ASCs)
10.3.5 Academic and Research Institutes
10.3.6 Others
10.4 Asia Pacific Spine Biologics Market (2019-2035) by Country
10.4.1 China
10.4.1.1 China Spine Biologics Market (2019-2035) by Product Type
10.4.2 Japan
10.4.2.1 Japan Spine Biologics Market (2019-2035) by Product Type
10.4.3 India
10.4.3.1 India Spine Biologics Market (2019-2035) by Product Type
10.4.4 ASEAN
10.4.4.1 ASEAN Spine Biologics Market (2019-2035) by Product Type
10.4.5 Australia
10.4.5.1 Australia Spine Biologics Market (2019-2035) by Product Type
10.4.6 Others
11 Latin America Spine Biologics Market (2019-2035)
11.1 Latin America Spine Biologics Market (2019-2035) by Product Type
11.1.1 Market Overview
11.1.2 Bone Graft
11.1.2.1 Spine Autografts
11.1.2.2 Spine Allografts
11.1.3 Bone Graft Substitutes
11.1.3.1 Bone Morphogenetic Proteins (BMP)
11.1.3.2 Demineralized Bone Matrix (DMB)
11.1.3.3 Synthetic Bone Grafts
11.1.4 Platelet Rich Plasma (PRP)
11.1.5 Bone Marrow Aspirate (BMAC) Therapy
11.2 Latin America Spine Biologics Market (2019-2035) by Surgery Type
11.2.1 Market Overview
11.2.2 Anterior Cervical Discectomy and Fusion (ACDF)
11.2.3 Transforaminal Lumbar Interbody Fusion (TLIF)
11.2.4 Posterior Lumbar Interbody Fusion (PLIF)
11.2.5 Anterior Lumbar Interbody Fusion (ALIF)
11.2.6 Lateral Lumbar Interbody Fusion (LLIF)
11.3 Latin America Spine Biologics Market (2019-2035) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Ambulatory Surgical Centers (ASCs)
11.3.5 Academic and Research Institutes
11.3.6 Others
11.4 Latin America Spine Biologics Market (2019-2035) by Country
11.4.1 Brazil
11.4.1.1 Brazil Spine Biologics Market (2019-2035) by Product Type
11.4.2 Argentina
11.4.2.1 Argentina Spine Biologics Market (2019-2035) by Product Type
11.4.3 Mexico
11.4.3.1 Mexico Spine Biologics Market (2019-2035) by Product Type
11.4.4 Others
12 Middle East and Africa Spine Biologics Market (2019-2035)
12.1 Middle East and Africa Spine Biologics Market (2019-2035) by Product Type
12.1.1 Market Overview
12.1.2 Bone Graft
12.1.2.1 Spine Autografts
12.1.2.2 Spine Allografts
12.1.3 Bone Graft Substitutes
12.1.3.1 Bone Morphogenetic Proteins (BMP)
12.1.3.2 Demineralized Bone Matrix (DMB)
12.1.3.3 Synthetic Bone Grafts
12.1.4 Platelet Rich Plasma (PRP)
12.1.5 Bone Marrow Aspirate (BMAC) Therapy
12.2 Middle East and Africa Spine Biologics Market (2019-2035) by Surgery Type
12.2.1 Market Overview
12.2.2 Anterior Cervical Discectomy and Fusion (ACDF)
12.2.3 Transforaminal Lumbar Interbody Fusion (TLIF)
12.2.4 Posterior Lumbar Interbody Fusion (PLIF)
12.2.5 Anterior Lumbar Interbody Fusion (ALIF)
12.2.6 Lateral Lumbar Interbody Fusion (LLIF)
12.3 Middle East and Africa Spine Biologics Market (2019-2035) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Ambulatory Surgical Centers (ASCs)
12.3.5 Academic and Research Institutes
12.3.6 Others
12.4 Middle East and Africa Spine Biologics Market (2019-2035) by Country
12.4.1 Saudi Arabia
12.4.1.1 Saudi Arabia Spine Biologics Market (2019-2035) by Product Type
12.4.2 United Arab Emirates
12.4.2.1 United Arab Emirates Spine Biologics Market (2019-2035) by Product Type
12.4.3 Nigeria
12.4.3.1 Nigeria Spine Biologics Market (2019-2035) by Product Type
12.4.4 South Africa
12.4.4.1 South Africa Spine Biologics Market (2019-2035) by Product Type
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Grants Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Initiatives
17.3 Analysis by Joint Ventures
17.4 Analysis by Leading Players
17.5 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (For Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia Pacific
18.1.5 Market Share Analysis: Others
18.2 Stryker Corporation
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Development
18.2.5 Certifications
18.3 Orthofix International N.V.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Development
18.3.5 Certifications
18.4 DePuy Synthes (Johnson & Johnson Services, Inc.)
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Development
18.4.5 Certifications
18.5 Zimmer Biomet
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Development
18.5.5 Certifications
18.6 Arthrex, Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Development
18.6.5 Certifications
18.7 Medtronic plc
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Development
18.7.5 Certifications
18.8 Organogenesis Inc.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Development
18.8.5 Certifications
18.9 Kuros Biosciences
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Development
18.9.5 Certifications
18.10 Nutech
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Development
18.10.5 Certifications
18.11 X-Spine Systems, Inc. (Bacterin International Holdings, Inc.)
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Development
18.11.5 Certifications
19 Global Spine Biologics Market – Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total branded market. The Informes de Expertos (IDE) team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.